AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 119 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $77,000 | +22.2% | 8,231 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $63,000 | +23.5% | 8,231 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $51,000 | -49.0% | 8,231 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $100,000 | +5.3% | 8,231 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $95,000 | +15.9% | 8,231 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $82,000 | -22.6% | 8,231 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $106,000 | -15.2% | 8,231 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $125,000 | -24.2% | 8,231 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $165,000 | -1.8% | 8,231 | -4.6% | 0.00% | 0.0% |
| Q2 2018 | $168,000 | -3.4% | 8,631 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $174,000 | +39.2% | 8,631 | -8.2% | 0.00% | +100.0% |
| Q4 2017 | $125,000 | -27.7% | 9,400 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $173,000 | 0.0% | 9,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $173,000 | -18.4% | 9,400 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $212,000 | -35.2% | 9,400 | 0.0% | 0.00% | -25.0% |
| Q4 2016 | $327,000 | +31.9% | 9,400 | -6.9% | 0.00% | +33.3% |
| Q3 2016 | $248,000 | +2.5% | 10,100 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $242,000 | -19.3% | 10,100 | -21.1% | 0.00% | -25.0% |
| Q1 2016 | $300,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |